Elite Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This webpage contains a free Environmental, Social and Governance assessment for Elite Pharmaceuticals Inc. The Disclosure score covers seventeen United Nations Sustainable Development Goals including: 'Gender Equality', 'Industry, Innovation & Infrastructure' and 'Peace, Justice & Strong Institutions'. If you work at Elite Pharmaceuticals Inc and you would like to use your ESG aseessment, please contact us.
Elite Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Elite Pharmaceuticals Inc | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Elite Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Does Elite Pharmaceuticals Inc disclose current and historical energy intensity?
Does Elite Pharmaceuticals Inc report the average age of the workforce?
Does Elite Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Does Elite Pharmaceuticals Inc disclose its ethnicity pay gap?
Does Elite Pharmaceuticals Inc disclose cybersecurity risks?
Does Elite Pharmaceuticals Inc offer flexible work?
Does Elite Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Elite Pharmaceuticals Inc disclose the number of employees in R&D functions?
Does Elite Pharmaceuticals Inc conduct supply chain audits?
Does Elite Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Elite Pharmaceuticals Inc conduct 360 degree staff reviews?
Does Elite Pharmaceuticals Inc disclose the individual responsible for D&I?
Does Elite Pharmaceuticals Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Elite Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Does Elite Pharmaceuticals Inc disclose water use targets?
Does Elite Pharmaceuticals Inc have careers partnerships with academic institutions?
Did Elite Pharmaceuticals Inc have a product recall in the last two years?
Does Elite Pharmaceuticals Inc disclose incidents of discrimination?
Does Elite Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Has Elite Pharmaceuticals Inc issued a profit warning in the past 24 months?
Does Elite Pharmaceuticals Inc disclose parental leave metrics?
Does Elite Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Does Elite Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Elite Pharmaceuticals Inc disclose the pay ratio of women to men?
Does Elite Pharmaceuticals Inc support suppliers with sustainability related research and development?
Does Elite Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Elite Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Elite Pharmaceuticals Inc involved in embryonic stem cell research?
Does Elite Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Does Elite Pharmaceuticals Inc disclose its waste policy?
Does Elite Pharmaceuticals Inc report according to TCFD requirements?
Does Elite Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Elite Pharmaceuticals Inc disclose energy use targets?
Does Elite Pharmaceuticals Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Elite Pharmaceuticals Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Elite Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Elite Pharmaceuticals, Inc. engages in the research, development, manufacture, and licensing of proprietary orally administered controlled-release drug delivery systems and products. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Hydromorphone HCl 8mg tablets for pains under the Dilaudid brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsules for cardiovascular diseases. The company also provides Oxycodone HCl immediate release 5mg, 10mg, 15mg, 20mg, and 30mg tablets for pains under Roxycodone brand; Trimipramine Maleate Immediate Release antidepressant capsules under the Surmontil brand; Methadone HCl tablets for pains under the Dolophine brand; and Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Immediate Release tablets for central nervous system diseases under the Adderall brand, as well as Dantrolene Sodium capsules for muscle relaxant under the Dantrium brand; and SequestOX, an immediate release Oxycodone with Naltrexone. In addition, it manufactures controlled-release products on a contract basis for third parties in the areas of pain, allergy, bariatric, and infection. Further, the company is developing a range of abuse deterrent opioid products. It has a manufacturing and license agreement with Epic Pharma LLC; development and license agreement with SunGen Pharma, LLC; and strategic marketing alliance with Glenmark Pharmaceuticals, Inc. USA, as well as Lannett Company. Inc. The company was founded in 1984 and is headquartered in Northvale, New Jersey.